

DKMS Collection Center gGmbH
DKMS is an international non-profit organization dedicated to the fight against blood cancer. With over 12.5 million registered stem cell donors worldwide, DKMS offers patients a second chance at life through research, donor search, and innovative therapies.
About DKMS
editDKMS is an international non-profit organization dedicated to the fight against blood cancer and other life-threatening blood diseases. Founded in 1991 in Germany by Dr. Peter Harf, inspired by the loss of his wife to leukemia, DKMS aims to find a matching stem cell donor for every patient. With over 12.5 million registered potential stem cell donors worldwide, DKMS has already given more than 120,000 patients a second chance at life.
Key Products and Services
editDKMS provides comprehensive support for medical professionals in the field of hematopoietic stem cell transplantation. This includes providing information, assisting in donor searches, and conducting HLA typing in their state-of-the-art Life Science Lab. The DKMS Stem Cell Bank is a global leader in providing cryopreserved peripheral blood stem cells for allogeneic transplants. Additionally, DKMS operates a global registry that makes donors from six countries available for international requests.
Mission and Values
editThe mission of DKMS is to raise awareness of blood cancer, recruit stem cell donors, and improve treatment options for blood diseases through its own research. DKMS is committed to providing every patient a second chance at life, regardless of geographic location or socioeconomic status. The organization works closely with volunteers and communities to promote the registration of new donors and enable life-saving donations.
Sustainability Goals and Initiatives
editDKMS actively works to improve transplantation opportunities in low- and middle-income countries. Through programs such as funding bone marrow transplant units for children in India and supporting patient accommodations in Chile, DKMS helps to expand access to life-saving therapies. The organization also promotes innovative research projects and awards scholarships annually to young scientists in the field of cell therapy and transplantation.
Commitment to Science and Research
editDKMS continuously invests in research and quality assurance programs to optimize the success rates of stem cell transplants. The organization operates its own clinical research unit and supports scientific projects worldwide. By providing resources and collaborating with international research institutions, DKMS contributes to the advancement of blood cancer treatment.
With a global network and a dedicated team of over 1,300 employees, DKMS is committed to improving the survival chances of blood cancer patients and saving lives worldwide.